Stay updated on Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now lists a specific Location (Charlotte, North Carolina) under Locations. The old North Carolina Locations entry and the HHS Vulnerability Disclosure link were removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:50:10.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:31:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate publications are about the study results, and a new Revision: v3.3.1 tag appears replacing the older v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:03.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Removed a generic NIH operating-status notice; the study details, eligibility criteria, outcomes, and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:23.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No notable content or layout changes were observed between the two screenshots. The page still displays the same study details, sections, and links as before.
    Difference
    0.4%
    Check dated 2025-11-03T01:17:12.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:07:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.